Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12551-014-0153-3 http://scihub22266oqcxt.onion/10.1007/s12551-014-0153-3 C5418425!5418425!28509978     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28509978&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28509978.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Biophys+Rev 2015 ; 7 (1): 117-25 Nephropedia Template TP {{tp|p=28509978|t=2015. Surgery for hypertrophic cardiomyopathy |pdf=|usr=}}{{28509978}} gab.com Text Surgery for hypertrophic cardiomyopathy JO: Biophys Rev http://www.kidney.de/pget.php?&tw=1&pmid=28509978 #FOAvip Hypertrophic cardiomyopathy (HCM) is a genetically determined cardiac disease characterised by otherwise unexplained myocardial hypertrophy of the left ventricle, and may result in left ventricular outflow tract obstruction. It is the most common cause of sudden cardiac death in young adults due to arrhythmias. Septal myectomy is a surgical treatment for HCM with moderate to severe outflow tract obstruction, and is indicated for patients with severe symptoms refractory to medical therapy. The surgical approach involves obtaining access to the interventricular septum via transaortic, transapical or transmitral approaches, and excising a portion of the hypertrophied myocardium to relieve the outflow tract obstruction. Large, contemporary series from centres experienced in septal myectomy patients have demonstrated a low early mortality of <2 %, excellent long-term survival that matches the general population, and durable relief of symptoms. Twit Text FOAVip Surgery for hypertrophic cardiomyopathy ????Biophys Rev http://www.kidney.de/pget.php?&tw=1&pmid=28509978 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28509978 #FOAvip English Wikipedia <ref>{{Cite pmid|28509978}}</ref> Surgery for hypertrophic cardiomyopathy #MMPMID28509978 Wu JJ; Seco M; Medi C; Semsarian C; Richmond DR; Dearani JA; Schaff HV; Byrom MJ; Bannon PG Biophys Rev 2015[Mar]; 7 (1): 117-25 PMID28509978show ga Hypertrophic cardiomyopathy (HCM) is a genetically determined cardiac disease characterised by otherwise unexplained myocardial hypertrophy of the left ventricle, and may result in left ventricular outflow tract obstruction. It is the most common cause of sudden cardiac death in young adults due to arrhythmias. Septal myectomy is a surgical treatment for HCM with moderate to severe outflow tract obstruction, and is indicated for patients with severe symptoms refractory to medical therapy. The surgical approach involves obtaining access to the interventricular septum via transaortic, transapical or transmitral approaches, and excising a portion of the hypertrophied myocardium to relieve the outflow tract obstruction. Large, contemporary series from centres experienced in septal myectomy patients have demonstrated a low early mortality of <2 %, excellent long-term survival that matches the general population, and durable relief of symptoms. äSurgery for hypertrophic cardiomyopathy (epmc).pdf DeepDyve Pubget Overpricing